SCHEMBL1378677

SCHEMBL1378677

C1CCN([Si](N2CCCC2)(N2CCCC2)N2CCCC2)C1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1449190 0.73
SCHEMBL28344073 0.67
SCHEMBL17701567 0.67
SCHEMBL17701572 0.67
SCHEMBL378577 0.67
SCHEMBL8647505 0.67
SCHEMBL17691353 0.67
SCHEMBL17691335 0.67
SCHEMBL17691340 0.65 MGLL (0.30)
SCHEMBL918211 0.65 MGLL (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110573652-B Novel formulations for depositing silicon doped hafnium oxide as ferroelectric material 弗萨姆材料美国有限责任公司 2022-07-22 CN claimed
US-11193206-B2 Formulation for deposition of silicon doped hafnium oxide as ferroelectric materials VERSUM MATERIALS US, LLC (US) 2021-12-07 US claimed
CN-110573652-A Novel formulations for the deposition of silicon-doped hafnium oxide as ferroelectric material 弗萨姆材料美国有限责任公司 2019-12-13 CN claimed
US-20180265967-A1 Formulation for Deposition of Silicon Doped Hafnium Oxide as Ferroelectric Materials VERSUM MATERIALS US, LLC (US) 2018-09-20 US claimed
WO-2018170125-A1 NEW FORMULATION FOR DEPOSITION OF SILICON DOPED HAFNIUM OXIDE AS FERROELECTRIC MATERIALS VERSUM MATERIALS US, LLC (US) 2018-09-20 WO claimed
CN-110573652-B Novel formulations for depositing silicon doped hafnium oxide as ferroelectric material 弗萨姆材料美国有限责任公司 2022-07-22 CN disclosed
US-11193206-B2 Formulation for deposition of silicon doped hafnium oxide as ferroelectric materials VERSUM MATERIALS US, LLC (US) 2021-12-07 US disclosed
CN-110573652-A Novel formulations for the deposition of silicon-doped hafnium oxide as ferroelectric material 弗萨姆材料美国有限责任公司 2019-12-13 CN disclosed
WO-2018170125-A1 NEW FORMULATION FOR DEPOSITION OF SILICON DOPED HAFNIUM OXIDE AS FERROELECTRIC MATERIALS VERSUM MATERIALS US, LLC (US) 2018-09-20 WO disclosed
US-20180265967-A1 Formulation for Deposition of Silicon Doped Hafnium Oxide as Ferroelectric Materials VERSUM MATERIALS US, LLC (US) 2018-09-20 US disclosed
US-8399695-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2013-03-19 US disclosed
US-8399695-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2013-03-19 US disclosed
US-20110293852-A1 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. 2011-12-01 US disclosed
US-7332618-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2008-02-19 US disclosed
US-7332618-B2 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. (US) 2008-02-19 US disclosed
WO-2008002415-A2 PRECURSORS FOR DEPOSITING SILICON CONTAINING FILMS AND PROCESSES THEREOF PRAXAIR TECHNOLOGY, INC. (US) 2008-01-03 WO disclosed
US-20070299274-A1 Organometallic compounds PRAXAIR TECHNOLOGY, INC. 2007-12-27 US disclosed
EP-1805195-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2007-07-11 EP disclosed
WO-2006036538-A2 ORGANOMETALLIC PRECURSOR COMPOUNDS PRAXAIR TECHNOLOGY, INC. (US) 2006-04-06 WO disclosed
US-20060068102-A1 Organometallic precursor compounds PRAXAIR TECHNOLOGY, INC. 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110293852-A1 ORGANOMETALLIC PRECURSOR COMPOUNDS MSMO1, NNMT, DNMT1 CA1 2703/4885CA2 3829/4885POLB 757/4885
US-20070299274-A1 Organometallic compounds NR1H3, NR1H2, NR1I3 CA1 2221/4885CA2 2897/4885POLB 3889/4885
US-20060068102-A1 Organometallic precursor compounds MSMO1, NNMT, DNMT1 CA1 2703/4885CA2 3829/4885POLB 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.